Evidence map›Paper›PMID 32937916›Full record

ReviewInternational journal of molecular sciences2020

Noncanonical Constitutive Androstane Receptor Signaling in Gene Regulation.

Yuliya A Pustylnyak, Lyudmila F Gulyaeva, Vladimir O Pustylnyak

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Regulation of Cytochrome P450 2a5 byFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yuliya A PustylnyakZelman Institute for the Medicine and Psychology, Novosibirsk State University, Pirogova street, 1, 630090 Novosibirsk, Russia.
Lyudmila F GulyaevaZelman Institute for the Medicine and Psychology, Novosibirsk State University, Pirogova street, 1, 630090 Novosibirsk, Russia.
Vladimir O PustylnyakZelman Institute for the Medicine and Psychology, Novosibirsk State University, Pirogova street, 1, 630090 Novosibirsk, Russia.ORCID 0000-0003-0547-5534
Novosibirsk State University · RU

Funding

Russian Science Foundation 18-15-00021
6 · The paper itself

Abstract

The constitutive androstane receptor (CAR, NR1I3) is extremely important for the regulation of many physiological processes, especially xenobiotic (drug) metabolism and transporters. CAR differs from steroid hormone receptors in that it can be activated using structurally unrelated chemicals, both through direct ligand-binding and ligand-independent (indirect) mechanisms. By binding to specific responsive elements on DNA, CAR increases the expression of its target genes encoding drug-metabolizing enzymes and transporters. Therefore, CAR is mainly characterized as a ligand-dependent or ligand-independent transcription factor, and the induction of gene expression is considered the canonical mode of CAR action. Consistent with its central role in xenobiotic metabolism, CAR signaling includes a collection of mechanisms that are employed alongside the core transcriptional machinery of the receptor. These so-called noncanonical CAR pathways allow the receptor to coordinate the regulation of many aspects of cell biology. In this mini-review, we review noncanonical CAR signaling, paying special attention to the role of CAR in energy homeostasis and cell proliferation.

Indexed as

AnimalsCell ProliferationConstitutive Androstane ReceptorGene Expression RegulationHomeostasisHumansLigandsReceptors, Cytoplasmic and NuclearSignal TransductionConstitutive Androstane ReceptorLigandsNR1I3 protein, humanReceptors, Cytoplasmic and NuclearCARcell proliferationenergy homeostasisgene regulationnoncanonical signaling

Identifiers

PMID32937916
PMCPMC7555422
OpenAlexW3084499313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.